$1.08
-0.02 (-1.82%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,900.0% upside
Low Target
$19.68
Average Target
$21.60
High Target
$29.43
Current Price
$1.08
Current
$1.08
$1.08
Target
$21.60
$21.60
$19.68
$21.60 avg
$29.43
Scenario Analysis
Bear Case
$19.68
1,722.2%
Low target
Base Case
$21.60
+1,900.0%
Avg target
Bull Case
$29.43
+2,625.0%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$25.65
-95.8% from high
52-Week Low
$16.65
+-93.5% from low
Target vs 52W High
$21.60
-15.8% vs high
Next Earnings Report
Mar 5, 2026 · Before Market Open
17d
until earnings
EPS Est: $-0.27
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |